Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis.
Clin Infect Dis. 2019 May 30;68(12):2094-2098. doi: 10.1093/cid/ciy817.
Individuals with cryptococcal antigenemia are at high risk of developing cryptococcal meningitis if untreated. The progression and timing from asymptomatic infection to cryptococcal meningitis is unclear. We describe a subpopulation of individuals with neurologic symptomatic cryptococcal antigenemia but negative cerebral spinal fluid (CSF) studies.
We evaluated 1201 human immunodeficiency virus-seropositive individuals hospitalized with suspected meningitis in Kampala and Mbarara, Uganda. Baseline characteristics and clinical outcomes of participants with neurologic-symptomatic cryptococcal antigenemia and negative CSF cryptococcal antigen (CrAg) were compared to participants with confirmed CSF CrAg+ cryptococcal meningitis. Additional CSF testing included microscopy, fungal culture, bacterial culture, tuberculosis culture, multiplex FilmArray polymerase chain reaction (PCR; Biofire), and Xpert MTB/Rif.
We found 56% (671/1201) of participants had confirmed CSF CrAg+ cryptococcal meningitis and 4% (54/1201) had neurologic symptomatic cryptococcal antigenemia with negative CSF CrAg. Of those with negative CSF CrAg, 9% (5/54) had Cryptococcus isolated on CSF culture (n = 3) or PCR (n = 2) and 11% (6/54) had confirmed tuberculous meningitis. CSF CrAg-negative patients had lower proportions with CSF pleocytosis (16% vs 26% with ≥5 white cells/μL) and CSF opening pressure >200 mmH2O (16% vs 71%) compared with CSF CrAg-positive patients. No cases of bacterial or viral meningitis were detected by CSF PCR or culture. In-hospital mortality was similar between symptomatic cryptococcal antigenemia (32%) and cryptococcal meningitis (31%; P = .91).
Cryptococcal antigenemia with meningitis symptoms was the third most common meningitis etiology. We postulate this is early cryptococcal meningoencephalitis. Fluconazole monotherapy was suboptimal despite Cryptococcus-negative CSF. Further studies are warranted to understand the clinical course and optimal management of this distinct entity.
NCT01802385.
未经治疗的隐球菌抗原血症患者有发展为隐球菌性脑膜炎的高风险。从无症状感染到隐球菌性脑膜炎的进展和时间尚不清楚。我们描述了一组具有神经症状性隐球菌抗原血症但中枢神经系统(CSF)研究阴性的人群。
我们评估了在乌干达坎帕拉和姆巴拉拉因疑似脑膜炎住院的 1201 名人类免疫缺陷病毒(HIV)阳性个体。比较了具有神经症状性隐球菌抗原血症和阴性 CSF 隐球菌抗原(CrAg)的参与者与确诊 CSF CrAg+隐球菌性脑膜炎的参与者的基线特征和临床结局。CSF 的其他检测包括显微镜检查、真菌培养、细菌培养、结核分枝杆菌培养、多重 FilmArray 聚合酶链反应(PCR;Biofire)和 Xpert MTB/Rif。
我们发现 56%(1201 例中的 671 例)的参与者有确诊的 CSF CrAg+隐球菌性脑膜炎,4%(1201 例中的 54 例)有神经症状性隐球菌抗原血症和阴性 CSF CrAg。在阴性 CSF CrAg 的患者中,9%(5/54)在 CSF 培养(n=3)或 PCR(n=2)中分离出隐球菌,11%(6/54)有确诊的结核性脑膜炎。CSF CrAg 阴性患者的 CSF 白细胞增多(≥5 个白细胞/μL)比例较低(16% vs 26%),CSF 开放压>200mmH2O 比例较低(16% vs 71%),与 CSF CrAg 阳性患者相比。通过 CSF PCR 或培养未检测到细菌性或病毒性脑膜炎。症状性隐球菌抗原血症(32%)和隐球菌性脑膜炎(31%;P=.91)的院内死亡率相似。
有脑膜炎症状的隐球菌抗原血症是第三大常见的脑膜炎病因。我们推测这是早期的隐球菌脑膜脑炎。尽管 CSF 为阴性,但氟康唑单药治疗效果不佳。需要进一步研究以了解这种独特实体的临床过程和最佳治疗方法。
NCT01802385。